I am a biologist with a research trajectory centered on the biological effects of air pollution exposure. My work integrates biochemical, cellular, and physiological approaches to understand how environmental pollutants—particularly fine particulate matter (PM2.5)—drive vascular injury and cardiometabolic dysfunction. My research explores how macrophage-mediated inflammatory pathways contribute to vascular damage triggered by PM2.5 exposure, and how pharmacological interventions such as colchicine may mitigate these effects. I also collaborate on studies involving metabolic disorders, obesity, menopause, exercise physiology, hypercholesterolemia, and neurodegeneration, with a common focus on inflammatory and oxidative mechanisms. Currently, my primary scientific focus is uncovering the molecular and cellular mechanisms by which macrophages modulate pollutant-induced vascular injury and identifying therapeutic strategies capable of preventing or reducing this damage.
I am a biologist with a research trajectory centered on the biological effects of air pollution exposure. My work integrates biochemical, cellular, and physiological approaches to understand how environmental pollutants—particularly fine particulate matter (PM2.5)—drive vascular injury and cardiometabolic dysfunction. My research explores how macrophage-mediated inflammatory pathways contribute to vascular damage triggered by PM2.5 exposure, and how pharmacological interventions such as colchicine may mitigate these effects. I also collaborate on studies involving metabolic disorders, obesity, menopause, exercise physiology, hypercholesterolemia, and neurodegeneration, with a common focus on inflammatory and oxidative mechanisms. Currently, my primary scientific focus is uncovering the molecular and cellular mechanisms by which macrophages modulate pollutant-induced vascular injury and identifying therapeutic strategies capable of preventing or reducing this damage.